Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyTue, 23 Jul 2024 07:45:06 +0200Wed, 03 Apr 2024 16:20:00 +0200Human medicines European public assessment report (EPAR): Sixmo, buprenorphine, Date of authorisation: 19/06/2019, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/sixmoHuman medicines European public assessment report (EPAR): Sixmo, buprenorphine, Date of authorisation: 19/06/2019, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/sixmoWed, 03 Apr 2024 16:20:00 +0200Human medicineSixmo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4743-en.pdfSixmo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4743-en.pdfWed, 03 Apr 2024 12:32:00 +0200Human medicine